Stocks
AnaptysBio (ANAB) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 3.86 | 20.3 | 9.36 | 3.92 | 2.75 | 0.19 | |||
| Changes by years, y/y, % | -45% | +426% | -54% | -58% | -30% | -17.0% | |||
AnaptysBio. Debt/EBITDA
AnaptysBio. Debt/EBITDA, changes, %
AnaptysBio (ANAB) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| Debt/EBITDA | 3.58 | 3.32 | 3.05 | 2.60 | 0.19 | 0.19 | ||
| Changes by years, y/y, % | -48% | -24% | -15% | -35% | -95% | |||
| Changes by quarters, q/q, % | -10% | -7% | -8% | -15% | -93% | |||
